










Case ReportUnusual Collision Tumor of Ovary:
Endometrioid Adenocarcinoma and Teratoma
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Collision tumors represent the coexistence of 2 histologically dis-
tinct tumors adjacent to one another in the same organ, without
admixture of the components of the tumors.1 Although uncommon,
hey have been described in almost all major organs, with a variety of
omponent pathologic features. The majority are diagnosed postop-
ratively after histologic examination. The origin of these tumors has
een debated. It is proposed that collision tumors could arise from 2
ifferent cell lines growing at the same time side by side or a chance
ccurrence of 2 tumors in the same organ. The other commonly held
iew is the origin from a common precursor pluripotent stem cell.
ancer is considered to be a disease of the stem cell, and given the
lasticity of the stem cell to differentiate this theory is made more
lausible.2 Ovarian collision tumors are rare. We report a case of
collision tumor of the ovary composed of teratoma and endometrioid
adenocarcinoma.
Case Report
A 71-year-old para I woman presented with a 4-month history of
abdominal swelling and postmenopausal bleeding. She attained
menopause at the age of 50 years and had no previous gynecologic
problems.Her pastmedical history was unremarkable and she was on
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Clinical Pra
● Collision tumors of the ovary are rare and can some-
times pose diagnostic and therapeutic challenges.
● They require careful pathologic review and multidisci-
plinary management to decide an appropriate treatment
and follow-up plan.
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the pelvis and reaching up to the umbilicus. CA125 levels were ele-
vated at 256 U/mL and carcinoembryonic antigen levels were nor-
mal. Pelvic ultrasonography showed a large complex mass in the
pelvis with cystic and solid components, measuring 27  19  15
cm, and neither ovary was visualized separately. Computed tomog-
raphy (Figure 1) confirmed the large complex mass occupying the
pelvis and lower abdomen. There was no ascites or presence of disease
elsewhere.
The risk of malignancy index (RMI) scoring system can be used to
predict the risk of malignancy of adnexal masses. It incorporates
ultrasonographic features, menopausal status, and preoperative
CA125 level, and is calculated using the equation: RMI score 
ultrasound score  menopausal score  CA125 level (in units per
illiliter). Her RMI was high at 2304 (3  3  256) and she
roceeded to surgery.
At surgery, a right ovarian mass measuring 40 cm was found to
lmost reach the inferior surface of the liver, with a cystic component
n the abdomen and a solid component in the pelvis. The tumor was
dherent to the right pelvic side wall, anterior surface of the rectum
nd sigmoid colon, and back of the uterus. The adhesions were lysed,
nd a total abdominal hysterectomy, bilateral salpingo-oophorec-
omy was carried out, along with right pelvic node dissection and
nfracolic omentectomy.
The gross specimen showed replacement of the right ovary by a
olid lobular tumor with an adjacent cyst having a mural nodule with
ultiple small cysts (Figure 2A). The left ovary, fallopian tube, and
terus were grossly unremarkable. The microscopic findings were
ery interesting. There were 2 main histologic components. The first
ice Points
● The dominant pathologic feature and its influence
on prognosis need to be considered while making
decisions on appropriate adjuvant therapy.
o. 1, 33-6 © 2012 Elsevier Inc. All rights reserved.
rioid adenocarcinoma, Teratomact
5, Nomponent was a teratomawith a variety ofmature elements.Within
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34 Cthe teratomatous component there were foci of carcinoid, which
were positive for chromogranin and CD56 (Figure 2B and D), and a
yolk sac tumor that was positive for alpha fetoprotein (Figure 2C).
There were also scattered foci of immature neuroepithelium consis-
tent with immature teratoma (Figure 2E). The second major com-
ponent was that of a poorly differentiated adenocarcinoma with both
glandular and solid elements (Figure 2F). The solid elements were
composed of cells with a rather spindled appearance. Diffuse posi-
tivity for EMA, Ber-EP4, and cytokeratin markers is consistent with
the carcinoma and the morphologic features, and positive staining
with CK7, ER, CA125, and vimentin is supportive of endometrioid
adenocarcinoma.
In summary, this was a stage IA collision tumor of ovary composed
of a teratomatous neoplasm with components of an immature tera-
toma, yolk sac tumor, and carcinoid tumor, and a poorly differenti-
ated endometrioid adenocarcinoma.
The patient received 6 cycles of adjuvant carboplatin chemother-
apy and is currently on surveillance.
Discussion
Collision tumors involving the ovary are quite rare, and various
combinations have been reported. They include combinations of
cystadenocarcinoma and dermoid cyst, teratoma and mucinous cys-
tadenocarcinoma,2 carcinosarcoma and dermoid cyst,3 choriocarci-
noma and cystadenoma,4 sarcoma and mucinous tumor,5 sarcoma
and serous carcinoma,6 serous cystadenoma and Sertoli-Leydig cell
tumor,7 and granulosa cell tumor and ovarian hepatoid carcinoma.8
Teratoma appears to be a more common component among the
reported combinations of collision tumors of the ovary. The collision
of teratoma and endometrioid adenocarcinoma described here has
not been reported previously to our knowledge. Could the endo-
metrioid adenocarcinoma have risen within the teratoma?Malignant
transformation, although uncommon, is a well-recognized compli-
Figure 1 Contrast-Enhanced Computed Tomographic Scan (Sag
Solid (White Arrows) and Cystic (Black Arrows) Compcation of teratoma. The majority of these transformations are squa-
linical Ovarian & Other Gynecologic Cancer June 2012mous cell carcinomas.9 Other uncommon transformations described
are carcinoid tumors and adenocarcinomas, as well as serous papillary
adenocarcinoma and clear cell carcinoma.
We are not aware of an endometrioid adenocarcinoma arising
from a teratoma being described in the literature. Ohishi et al
reported a case of ovarian tumor in a premenopausal woman,
composed of malignant germ cell tumor and epithelial tumor
with components of endometrioid adenocarcinoma and clear cell
adenocarcinoma.10 The germ cell component consisted of yolk
ac tumor, immature teratoma with neuroectodermal and rhab-
omyosarcomatous differentiation. However, they reported that
he epithelial component arose from the endometriosis rather
han from the teratoma.
We believe that our case is a collision tumor, although it is impos-
ible to exclude the possibility of endometrioid adenocarcinoma aris-
ng directly from the teratoma. Molecular studies of the tumors can
e helpful in defining the clonality and histogenesis of these tu-
ors.11 Furlan et al usedmicroallelotyping to define the clonal origin
f collision tumors of the gut.12 The molecular analysis, although
elpful to identify clonal origin of tumors, is a research method and
o our knowledge is not done routinely. We have not carried out
lonal analysis because we do not have such facilities at our center.
The collision tumors are diagnosed postoperatively because there
re no specific features that aid their diagnoses preoperatively. Kim et
l retrospectively analyzed radiologic findings in pathologically con-
rmed collision tumors associated with teratoma to identify features
hat might point to their existence before surgery.13 They found that
6 of 7 collision tumors had radiologic clues such as the presence of
nonfatty fluid in the cyst and a large solid component in the ovarian
mass, which pointed toward the presence of a collision tumor. Such
clues, in addition to frozen section analysis, could help in deciding on
further management, particularly the type and extent of surgery. In
and Axial Sections) Showing a Large Complex Mass With
ts Occupying the Pelvis and Lower Abdomenittal
onenour patient, there were no specific radiologic or intraoperative clues
Eliyaz Ahmed et alto the presence of collision tumor; that was revealed only by histo-
logic diagnosis postoperatively. It is therefore crucial to carefully
sample the areas to diagnose collision tumors.
The management of collision tumors can be challenging, particu-
Figure 2 Collision Tumor of the Ovary With Macroscopic and M
Solid Lobular Tumor with Adjacent Cyst Having Mura
Mature Elements, a Small Focus of Carcinoid (Bottom
& E Stain; 40). (C) Focal Glandular Yolk Sac Tumor
Magnification Showing Carcinoid and Mature Elemen
Neuroepithelium (Arrows) Among Mature Element (H




# H09-13113larly if the components of the collision tumor are of diverse histologictypes, affecting prognosis. The factors that need to be considered in
deciding further management after surgery are the most aggressive
component of the collision tumor and the stage, which will deter-
mine the prognosis. In our case, decision about further management
scopic Features. (A) Gross Photograph of Right Ovary Showing
ule with Multiple Small Cysts (Arrow). (B) Teratoma With
w) and Poorly Differentiated Adenocarcinoma (Top Arrow) (H
itive for Alpha Fetoprotein) (H & E Stain; 200). (D) Higher
E Stain; 400). (E) Scattered Focus of Immature
tain; 200). (F) Poorly Differentiated Endometrioid
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36 Ctures. Although the guidelines recommend extensive pelvic nodal
sampling for germ cell tumors confined to the ovaries/pelvis, in this
case there was no suggestion of tumor harboring germ cell compo-
nents either preoperatively or at surgery. The tumor was staged sur-
gically as FIGO stage I, and the multidisciplinary team felt that
further surgical staging was not required given the good prognosis
associated with the dominant components of the collision tumor. As
far as the teratomatous component is concerned, there is evidence
that a surveillance policy could be a reasonable choice in stage I
malignant ovarian germ cell tumors, as these carry good prognosis
and could be salvaged with platinum-based chemotherapy should
they relapse.14 The other component of collision tumor, poorly dif-
erentiated endometrioid adenocarcinoma, on its own is an indica-
ion for platinum-based adjuvant chemotherapy. Ovarian endo-
etrioid adenocarcinoma carries a much better prognosis compared
ith the other histologic variants, stage for stage.15 We discussed all
he options with the patient, and on balance we decided to offer
djuvant chemotherapy with single-agent carboplatin with active
urveillance, which was acceptable to the patient.
In summary, this is a unique collision tumor of the ovary, a tera-
oma coexisting with endometrioid adenocarcinoma, which, to our
nowledge, has not been reported previously. It is possible that en-
ometrioid adenocarcinoma could have arisen from a teratoma but
uch an event has not been reported.
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